Related by context. All words. (Click for frequent words.) 66 lymphocytosis 65 SSc 65 renal cell carcinomas 65 malignant neoplasms 65 CLL SLL 64 bleomycin 64 Doxil ® 64 HBeAg negative patients 63 papillary renal cell carcinoma 63 HIV HCV coinfected 63 myocardial necrosis 63 tipranavir ritonavir 63 paricalcitol 63 isoproterenol 63 hypoperfusion 63 FluCAM arm 63 immunostaining 63 thyroid carcinoma 63 leukocytosis 63 relapsed MM 63 ertapenem 62 pheochromocytoma 62 Immunohistochemical staining 62 pancreatic adenocarcinoma 62 NMIBC 62 hemoglobin Hb 62 node metastases 62 C. trachomatis 62 mononuclear cells 62 tumoral 62 lactate dehydrogenase LDH 62 chronic GVHD 62 methicillin susceptible Staphylococcus aureus 62 leukocyte count 62 colorectal carcinoma 62 neutrophil counts 62 serum cortisol 62 colorectal adenocarcinoma 62 enterococcal 62 severe neutropenia 62 airway hyperresponsiveness 62 paragangliomas 62 HSCT 62 metastatic neuroendocrine tumors 62 myeloperoxidase 62 seropositivity 62 alveolar epithelial cells 62 hepatorenal syndrome 61 basal cell carcinoma BCC 61 thrombocytopenic 61 colorectal carcinomas 61 histological subtype 61 chemoradiotherapy 61 cerebral vasospasm 61 metachronous 61 lymphocyte counts 61 ADPKD 61 pegylated liposomal doxorubicin 61 SUVmax 61 immunoreactivity 61 bioavailable testosterone 61 breast carcinomas 61 liver transplant recipients 61 MGd 61 metastatic malignant 61 breast carcinoma 61 Hypotension 61 cell carcinomas 61 micafungin 61 interleukins 61 nodal metastasis 61 leucopenia 61 prostate carcinoma 61 malignant neoplasm 61 tumor regressions 61 IFN beta 61 lupus anticoagulant 61 biologic DMARD 61 bronchial epithelial cells 61 urothelial cancer 61 kallikrein 61 thalidomide Thalomid 61 ABCB1 61 aminotransferase 61 pT3 61 ovarian carcinoma 61 malignant lymphoma 61 myeloproliferative diseases 61 homozygotes 61 alanine aminotransferase ALT 61 mononuclear 61 haemolysis 61 invasive carcinomas 61 renal tumors 61 infarcts 61 neurological manifestations 61 underwent resection 61 epithelial tumors 61 Immunohistochemical analysis 61 piperacillin tazobactam 61 CIN2 + 61 SGPT 61 leukocyte counts 61 serological markers 60 nasopharyngeal carcinoma 60 thymoma 60 liposomal doxorubicin 60 INCB# [003] 60 hepatocellular carcinomas 60 haematological 60 chloride secretion 60 prostate cancer CaP 60 glomerular filtration 60 gastrointestinal perforation 60 timepoints 60 ritonavir boosted 60 pDC 60 transgene expression 60 uM 60 abacavir Ziagen 60 K#R [002] 60 adenocarcinomas 60 allergic airway inflammation 60 bacteraemia 60 pT2 60 transaminase elevations 60 Toxicities 60 serous ovarian cancer 60 cell lymphomas 60 serum antibody 60 CC genotype 60 advanced adenomas 60 β blockers 60 BRAF V#E 60 hamartomas 60 plasmacytoid 60 skeletal metastases 60 Leukemias 60 Waldenstrom macroglobulinemia 60 hematopoietic cancers 60 nonmelanoma skin cancers 60 immunoblotting 60 haematologic 60 HER2 expression 60 artery stenosis 60 HGPIN 60 gastric adenocarcinoma 60 carcinoid tumors 60 idiopathic PAH 60 Intravenous immunoglobulin 60 lymphoma subtypes 60 cerebrospinal fluid CSF 60 tacrolimus ointment 60 HIF PHI 60 urothelial carcinoma 60 pancreatic carcinoma 60 hepatoma 60 IL 1ß 60 pulmonary metastases 60 histologic subtype 60 recurrent glioblastoma multiforme 60 bronchioloalveolar carcinoma 60 S. aureus isolates 60 prostate cancer PCa 60 biochemical relapse 60 Escherichia coli Klebsiella pneumoniae 60 prolonged QT interval 60 hepatocellular carcinoma HCC 60 SCCHN 60 rebleeding 60 CP CPPS 60 #F FDG 60 anemia hemoglobin 60 nephrotoxicity 60 plasma renin activity 60 gefitinib Iressa 60 intracranial hemorrhage ICH 60 gastric carcinoma 60 serum homocysteine 60 Squamous 60 idebenone 59 squamous cell carcinoma SCC 59 pulmonary arterial 59 neutrophil count 59 splenectomized patients 59 carcinoid 59 cervical lymph nodes 59 Circulating tumor cells 59 Cardiotoxicity 59 viremic 59 cidofovir 59 IL#B 59 endometrioid 59 Non inferiority 59 Papillary 59 inducible nitric oxide synthase 59 leukoencephalopathy 59 peripheral blood mononuclear 59 allogeneic HSCT 59 PSA nadir 59 neoplasias 59 ventricular myocardium 59 ductal carcinomas 59 reticulocytes 59 imipenem 59 AZT zidovudine Retrovir 59 baseline LDH 59 somatic mutation 59 follicular lymphomas 59 hyperprolactinemia 59 Staphylococcus aureus infections 59 bronchogenic carcinoma 59 hepatic cirrhosis 59 hemorrhagic cystitis 59 hyperalgesia 59 cinacalcet 59 familial amyloidotic polyneuropathy FAP 59 bullous 59 invasive ductal 59 leukemia AML 59 aspartate aminotransferase 59 urothelial 59 enteroviral infection 59 nondiabetic patients 59 circulating lymphocytes 59 lactate dehydrogenase 59 argatroban 59 CD3 + 59 gastrointestinal stromal tumors GISTs 59 PaO 2 59 Kinoid 59 splenic 59 isoprostane 59 NRTI resistance 59 squamous 59 tumor necrosis 59 dimeglumine 59 indinavir 59 invasive candidiasis 59 isoenzyme 59 colorectal adenoma 59 CANCIDAS 59 granulocyte 59 trastuzumab Herceptin ® 59 PsA 59 gene polymorphism 59 pretransplant 59 histopathologic examination 59 HBV genotype 59 thyrotropin 59 differentially expressed genes 59 NF kappaB activation 59 tigecycline 59 Kepivance 59 osteosarcomas 59 Noxafil 59 MALT lymphoma 59 tryptase 59 Hematologic 59 interstitial pneumonia 59 ERK signaling 59 metaplasia 59 Dacogen decitabine 59 μg ml 59 neoplastic cells 59 underwent surgical resection 59 HNSCC 59 immunopathology 59 BARACLUDE ® 59 herpesviruses 59 rotaviruses 59 urothelium 59 MGUS 59 hematologic toxicity 59 EGF receptors 59 symptomatic intracranial 59 MRSA isolates 59 cytopenia 59 HbF 59 colon carcinoma 59 fluvastatin 59 pancytopenia 59 epithelioid 59 neutropenic patients 59 myeloablative 59 mediated apoptosis 59 EGFR mutant 59 haematopoietic stem cell 59 elevated LDH 59 macrolide antibiotic 59 carcinoids 59 Yondelis ® 59 cisplatin resistant 59 MBq 59 S aureus 59 urothelial bladder cancer 59 DFMO 59 nutlin 3a 59 metastatic lymph nodes 59 hepatic fibrosis 59 epoetin beta 59 immune globulin intravenous 59 Clusterin 59 isotypes 59 ALT elevations 59 hypocalcaemia 59 anagrelide 59 fluconazole resistant 59 Endometrial 59 imatinib Gleevec 58 docetaxel Taxotere ® 58 mesangial 58 T#I [002] 58 Cell Lymphoma CTCL 58 daunorubicin 58 somatostatin analog 58 immunocompetent 58 cGy 58 lymphadenopathy 58 azacytidine 58 localized renal 58 monoclonal anti 58 aminotransferases 58 KRAS status 58 neovascular 58 lymphoid malignancies 58 ALT flares 58 antitumor effect 58 BALF 58 thyroglobulin 58 S. enterica 58 D#N 58 nicardipine 58 irbesartan 58 chronic HBV 58 HBV genotypes 58 N. gonorrhoeae 58 hepatitis C genotype 58 nanomolar 58 follicular thyroid cancer 58 HeFH 58 linezolid resistant 58 allogeneic hematopoietic stem cell 58 Angioedema 58 alkaline phosphatase ALP 58 rituximab Rituxan 58 HER2 positive cancers 58 microvessel density 58 malignant lymphomas 58 plasma pharmacokinetics 58 T. pallidum 58 Neulasta ® 58 steroid dexamethasone 58 antibody titer 58 efalizumab 58 nonmetastatic 58 pathologic diagnosis 58 follicular lymphoma FL 58 trabectedin 58 E. faecalis 58 bacteria Pseudomonas 58 KRAS mutations occur 58 cutaneous melanoma 58 streptokinase 58 erythropoietin stimulating agents 58 mTOR inhibitors 58 mucinous 58 inhibitor RG# 58 pain palliation 58 Legg Calvé Perthes disease 58 cutaneous squamous cell carcinoma 58 hypothalamic pituitary 58 T2 lesions 58 CTEPH 58 osteochondromas 58 LPS induced 58 leukemic transformation 58 ano genital warts 58 viral reactivation 58 SCIg 58 cervical carcinoma 58 TEAEs 58 TIMP 1 58 Neutrophil 58 polycythemia vera PV 58 leukemia CLL 58 p# biomarker 58 ZACTIMA 58 Platinol ® cisplatin 58 ^ sup #m 58 Alkaline Phosphatase 58 atazanavir ritonavir 58 Sprague Dawley rats 58 bronchoalveolar lavage 58 CMV disease 58 granulomatous 58 preoperative PSA 58 nelfinavir 58 proteolytic cleavage 58 papillary carcinoma 58 cytopenias 58 CsA 58 hemoglobin hematocrit 58 cefotaxime 58 Myelodysplastic Syndrome MDS 58 virologic failures 58 S. Typhimurium 58 hyperplastic 58 ductal lobular 58 mitomycin 58 PTLD 58 circulating endothelial 58 recurrent venous thromboembolism 58 rFSH 58 subcutaneous immunoglobulin 58 alefacept 58 radioiodine therapy 58 calculi 58 hemagglutination inhibition 58 adrenocortical cancer 58 demyelinating 58 PBMCs 58 V#F mutation 58 AST ALT 58 human chorionic gonadotropin hCG 58 von Willebrand 58 HLA A2 58 TT genotype 58 platelet dysfunction 58 pg ml 58 recombinant erythropoietin 58 viral titers 58 cholangiocarcinoma 58 extracapsular extension 58 benzimidazole 58 prostate carcinomas 58 plasma creatinine 58 PEG IFN 58 heterozygotes 58 vasoactive 58 injected subcutaneously 58 microbiologically evaluable 58 antibody titers 58 effector function 58 fibrin deposition 58 phototoxicity 58 haematopoietic 58 rFVIIa 58 TNFalpha 58 lymphoproliferative disorders 58 rt PA 58 fig. S2 58 candidemia 58 supernatants 58 mutated K ras 58 hypophosphatemia 58 prucalopride 58 pentoxifylline 58 radiosensitivity 58 Pemetrexed 58 lung carcinomas 58 p = #.# [003] 58 carcinoembryonic antigen 58 EGFR HER2 58 RRM1 58 motoneurons 58 serologically 58 CMV infection 58 epithelial ovarian cancer 58 seropositive patients 58 rs# [004] 58 C. perfringens 58 serum creatinine levels 58 ara C 58 idraparinux 58 atherothrombotic disease 58 multikinase inhibitor 58 familial ALS 58 mycophenolate mofetil 58 Histopathological 58 receptor tyrosine kinase inhibitor 58 Enterobacter cloacae 58 Kupffer cells 58 achieved ACR# 58 GSTP1 58 octreotide LAR 58 Gleevec resistant 58 vasopressor 58 Cutaneous T 58 cardiac dysfunction 58 IOP lowering 58 P. acnes 58 macroalbuminuria 58 specific antigen PSA 58 Critical Limb Ischemia CLI 58 lung metastases 58 mycobacterial 58 Western blotting 58 lavage fluid 58 basal cell nevus syndrome 58 total thyroidectomy 58 lymphoid organs 58 allergic inflammation 58 K ras mutations 58 bFGF 58 intestinal metaplasia 58 hepatic enzymes 58 fulminant hepatic failure 58 tuberculin skin testing 58 intrahepatic 58 pyrazinamide 58 sclerosing 57 thyrotoxicosis 57 troponins 57 ductal adenocarcinoma 57 RoACTEMRA 57 creatine kinase CK 57 leiomyomas 57 cynomolgus monkeys 57 HER2 overexpression 57 monocytes macrophages 57 Myoglobin 57 bovine thrombin 57 histologic subtypes 57 daily subcutaneous injections 57 Cystatin C 57 Neoplasms 57 GH deficiency 57 57 Neisseria gonorrhoeae 57 pro inflammatory cytokines 57 airway hyper responsiveness 57 somatostatin analogs 57 HepG2 cells 57 myeloproliferative neoplasms 57 mesotheliomas 57 GG genotype 57 Allogeneic 57 liposomal amphotericin B 57 depsipeptide 57 nucleated cells 57 eosinophil count 57 carcinoid tumor 57 PAOD 57 serum urate levels 57 MIC# [001] 57 ALT elevation 57 IFN g 57 Cytotoxic T 57 histologically proven 57 distant metastasis 57 torsade de pointes 57 ANCA associated 57 coexpression 57 hemoglobin concentration 57 esophageal squamous cell carcinoma 57 salmeterol fluticasone propionate 57 autologous transplants 57 alkylating agent 57 galiximab 57 pimecrolimus cream 57 neoplastic 57 viremia 57 histologies 57 Platelet counts 57 ERBB2 57 tissue transglutaminase 57 Fas ligand 57 serotonin synthesis 57 VZV 57 TIMP 57 bone marrow stromal cells 57 acute lymphoblastic 57 arterial calcification 57 Adenomas 57 HBsAg 57 neuroendocrine cancers 57 murine models 57 renal toxicity 57 transfected cells 57 lymphocytic 57 Atypical Hemolytic Uremic Syndrome 57 seronegative 57 metastatic malignant melanoma 57 TP# mutations 57 myopathies 57 IFNs 57 Moraxella catarrhalis 57 nonsmall cell lung cancer 57 polymorphonuclear leukocytes 57 retransplantation 57 antiangiogenic therapy 57 alpha1 57 hematologic disorders 57 Diffuse Large B 57 GBM tumors 57 HDACi 57 nadolol 57 aortic atherosclerosis 57 variant alleles 57 intratumoral injection 57 TRAIL induced apoptosis 57 atherogenic dyslipidemia 57 pmol L 57 db db mice 57 LTBI 57 intestinal mucosal 57 antimuscarinic 57 eosinophilia 57 hemagglutination 57 induced sputum 57 Cytoxan 57 BCNS 57 corticosteroid therapy 57 IGFBP 3 57 HRCT 57 IgG antibody 57 albicans 57 lung adenocarcinomas 57 hepatectomy 57 LV ejection fraction 57 bronchoalveolar lavage BAL 57 E selectin 57 pleural fluid 57 ERalpha 57 monocytic 57 bendamustine 57 IIIb 57 HBeAg seroconversion 57 induced cytotoxicity 57 GABHS 57 ULORIC 57 systolic dysfunction 57 fluticasone salmeterol 57 metastatic RCC 57 Neisseria meningitidis 57 GW# [003] 57 FLT3 57 interleukin IL -# 57 pneumococcal serotypes 57 cathepsin B 57 brain parenchyma 57 glycated hemoglobin levels 57 hemodilution 57 NOD SCID mice 57 humoral responses 57 HBeAg negative 57 CRF antagonists 57 posaconazole 57 leiomyoma 57 cerebral ischemia 57 BRAF mutations 57 IgA antibodies 57 meropenem 57 allele frequency 57 microg 57 Bacteremia 57 HCV replicon 57 Enzastaurin 57 elastase 57 NSCLC tumors 57 experimental autoimmune encephalomyelitis 57 chronic periodontitis 57 urinary excretion 57 kidney cysts 57 EGFR receptor 57 juvenile idiopathic arthritis 57 mIU ml 57 Lp PLA 2 57 microglial activation 57 myeloproliferative 57 clinically evaluable 57 HLA B# 57 receptor blocker 57 resected pancreatic cancer 57 busulfan 57 HLA DRB1 * 57 papillary thyroid carcinoma 57 variceal bleeding 57 macrolide resistance 57 osteoclastic 57 metastatic GIST 57 urine albumin 57 demonstrated antitumor activity 57 secondary hyperparathyroidism 57 ganciclovir 57 glomerular 57 variant allele 57 JAK2 enzyme 57 muscarinic receptors 57 CALGB # [002] 57 alanine aminotransferase 57 pyridostigmine 57 metastatic lesions 57 viraemia 57 COPAXONE R 57 HCV infections 57 pan HDAC inhibitor 57 varicella infection 57 proton MR spectroscopy 57 bcl 2 57 CD# upregulation 57 stem cell transplantations 57 bronchial hyperresponsiveness 57 genital herpes infections 57 lenalidomide Revlimid R 57 relapsing remitting MS RRMS 57 LV dysfunction 57 clinico pathological 57 allograft rejection 57 colony stimulating factors 57 bronchoalveolar lavage fluid 57 IGFD 57 transgenic rats 57 antineoplastic 57 inhibin 57 HbA 1c levels 57 percutaneous transluminal coronary angioplasty 57 hyperammonemia 57 μmol L 57 vWF 57 mutated KRAS 57 flavopiridol 57 cerebral infarctions 57 kidney urologic 57 Malignant Melanoma 57 serum lipid levels 57 undetectable HBV DNA 57 syngeneic 57 hepato 57 peritumoral 57 rifamycins 57 genes differentially expressed 57 ceftazidime 57 chlamydial 57 triiodothyronine 57 PEDF 57 NeoRecormon 57 cTnI 57 myogenic 57 esophageal acid 57 Amplimexon 57 Trandolapril 57 prostate adenocarcinoma 57 NGAL 57 myeloproliferative disorder 57 squamous cell lung cancer 57 fumagillin nanoparticles 57 STRIDE PD 57 basiliximab 57 plasma kallikrein 57 P aeruginosa 57 lymph node metastasis 57 immunized mice 57 seminoma 57 Genotypes 57 Hodgkin lymphoma HL 57 deoxy 57 de novo AML 57 erythropoiesis 57 stage IIIB 57 mITT population 57 chemoresistance 57 T2DM 57 beta lactam antibiotic 57 EBV infection 57 serum concentrations 57 null responder 57 invasive aspergillosis 56 Sjögren syndrome 56 brivanib 56 isolated systolic hypertension 56 cardiac toxicity 56 mononuclear cell 56 serum antibodies 56 malignant prostate 56 synovial 56 iodixanol 56 Aplidin 56 allogeneic bone marrow 56 neointimal 56 acromegalic patients 56 missense mutation 56 cytotoxic therapies 56 superficial bladder cancer 56 cutaneous lesions 56 fluoroquinolone resistance 56 mol L 56 malignant pleural mesothelioma 56 Tumor Necrosis Factor 56 HLA DR4 56 Candida infection 56 alteplase 56 lymphoid cells 56 TNF α 56 cytologically confirmed 56 gastrointestinal stromal tumors GIST 56 Granulocyte Colony Stimulating Factor 56 K#N 56 BCR ABL mutations 56 anthracycline chemotherapy 56 oesophageal squamous cell carcinoma 56 erythroid 56 Asymptomatic 56 ALT normalization 56 distant metastases 56 thromboembolic events 56 Prostatitis 56 Ribavirin causes 56 systemic amyloidosis 56 alkaline phosphatase 56 BPS IC 56 Tacrolimus 56 ischemia reperfusion injury 56 denileukin diftitox 56 IFN α 56 oral FTY# 56 Beta catenin pathway 56 ug kg 56 Upregulation 56 isoprostanes 56 HBeAg positive 56 Juvenile Idiopathic Arthritis 56 Degarelix 56 bacterium Neisseria meningitidis 56 glioblastoma tumors 56 agonist induced 56 5 Fluorouracil 56 proto oncogene 56 ischemia reperfusion 56 Prostatic 56 Dasatinib 56 vasodilatation 56 grade cervical intraepithelial 56 breast cancer metastasis 56 Glypromate 56 mepolizumab 56 intracellular Ca 2 56 tumor xenograft models 56 p tau 56 #Gy 56 NAGS deficiency 56 elevated transaminases 56 tumorigenicity 56 melanocytic nevi 56 pleurodesis 56 ependymomas 56 chimeric monoclonal antibody 56 micrometastasis 56 IGFBP 56 infused intravenously 56 glomerulonephritis 56 seminomas 56 cranial irradiation 56 bronchodilatory 56 Mitomycin C 56 tissue oxygenation 56 HCV infected 56 CHOP chemotherapy 56 nodular lesions 56 hyperoxia 56 MDR1 56 IL 1β 56 p = NS 56 interferon IFN 56 S. aureus infections 56 Monocyte 56 MabCampath 56 Plasma concentrations 56 huN# DM1 56 endogenous EPO 56 colorectal tumor 56 cytokeratin 56 trophoblast cells 56 ischemic lesions 56 #OHD 56 pDCs 56 Trichophyton rubrum 56 nitrofurantoin 56 cis retinoic acid 56 Retreatment 56 prospective multicenter study 56 transaminase 56 nosocomial pneumonia 56 SHPT 56 NF kB pathway 56 neointimal hyperplasia 56 NSABP B 56 GHRH 56 hyperintensity 56 induced apoptosis 56 colorectal cancer CRC 56 5FU 56 Fludarabine 56 unconjugated 56 adrenocortical 56 intravenous bisphosphonates 56 QVAR R 56 immunofluorescence staining 56 â ‰ ¥ 56 pelvic lymphadenectomy 56 splenocytes 56 hypomethylation 56 intraperitoneally 56 Stenting Trial CREST 56 VEGF receptor 56 prednisone prednisolone 56 4mg/kg 56 Acute Decompensated Heart Failure 56 choroidal neovascularization 56 μg L 56 Streptococcus pyogenes 56 cystatin C 56 Nilotinib 56 osteoblastic 56 Cytogenetic 56 BoNT 56 Cyclosporine 56 genotypic resistance 56 palifermin 56 Chronic Myelogenous Leukemia CML 56 C. albicans 56 erythropoietic 56 Lymphoid 56 MTT assay 56 Immunohistochemistry 56 paraprotein 56 achieved sustained virological 56 carotid artery thickness 56 GISTs 56 HLA DR 56 capsular polysaccharide 56 infarcted myocardium 56 tyrosine kinase inhibitors TKIs 56 ABL1 56 Glatiramer acetate 56 VEGF induced 56 inotropic 56 neutralizing antibody 56 G6PD deficiency 56 constitutively expressed 56 immune thrombocytopenic purpura ITP 56 ADAMTS# 56 GNAQ 56 thrombi 56 carotid stenosis 56 epoetin alfa 56 solar keratosis 56 griseofulvin 56 Bendamustine 56 ximelagatran 56 BCG refractory 56 visceral metastases 56 MenACWY 56 Irinotecan 56 activin 56 serum leptin 56 sitaxsentan 56 immunoreactive 56 varices 56 SNCA 56 mycosis fungoides 56 epithelial ovarian 56 deferiprone 56 pancreatic lung 56 neoplastic lesions 56 CYPHER Stent 56 antiproliferative activity 56 serogroup 56 riociguat 56 microbiological eradication 56 ALI ARDS 56 aspirin clopidogrel 56 normal karyotype 56 pulmonary dysfunction 56 intestinal polyps 56 serum phosphate 56 Troponin T 56 histone deacetylase HDAC inhibitor 56 Thrombotic 56 untreated metastatic melanoma 56 proliferative retinopathy 56 rifamycin 56 cisplatin gemcitabine 56 gm dl 56 iNOS 56 epirubicin 56 acetazolamide 56 immunohistochemical staining 56 cardiogenic 56 Cellcept 56 periocular 56 IgA deficiency 56 Mycoplasma pneumoniae 56 Arranon 56 germline mutations 56 definite stent thrombosis 56 BRSV 56 intraepithelial